Background There is scarce data on the outcome of young patients aged 35 years and younger, who have been treated with neoadjuvant chemotherapy. The aim of this study is to evaluate the impact of body mass index (BMI) and various prognostic factors on pathologic response and survival in young patients with localized breast cancer
In locally advanced (LA) breast cancer (BC), neoadjuvant treatments have led to major achievements, ...
The role of neoadjuvant chemotherapy in locally advanced breast cancer is firmly established. There ...
Breast cancer represents the most frequent cancer among women in Western countries. Although physici...
Large and consistent evidence supports the role of body mass index (BMI) as a prognostic and predict...
Purpose: Large and consistent evidence supports the role of body mass index (BMI) as a prognostic an...
Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed t...
Incidence of breast cancer in patients aged < 20 years has been estimated to be 0.1 per 100,000 w...
Neoadjuvant chemotherapy (NAC) of breast cancer (BC) improves outcomes, especially in patients with ...
Background: Obesity seems to be associated with a poorer response to adjuvant chemotherapy in breast...
© Ivyspring International Publisher. This is an open-access article distributed under the terms of t...
The prevalence of obesity is rising worldwide including Sub-Saharan Africa just as the incidence of ...
Objectives: Excess adiposity is associated with several factors involved in carcinogenesis and breas...
Purpose: The effects of body mass index on pathologic complete response and survival have not been r...
Breast cancer rarely occurs in women below the age of 35 years. Data from various sources indicate t...
Background: Breast cancer in young women is associated with aggressive biology. We analyzed histopat...
In locally advanced (LA) breast cancer (BC), neoadjuvant treatments have led to major achievements, ...
The role of neoadjuvant chemotherapy in locally advanced breast cancer is firmly established. There ...
Breast cancer represents the most frequent cancer among women in Western countries. Although physici...
Large and consistent evidence supports the role of body mass index (BMI) as a prognostic and predict...
Purpose: Large and consistent evidence supports the role of body mass index (BMI) as a prognostic an...
Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed t...
Incidence of breast cancer in patients aged < 20 years has been estimated to be 0.1 per 100,000 w...
Neoadjuvant chemotherapy (NAC) of breast cancer (BC) improves outcomes, especially in patients with ...
Background: Obesity seems to be associated with a poorer response to adjuvant chemotherapy in breast...
© Ivyspring International Publisher. This is an open-access article distributed under the terms of t...
The prevalence of obesity is rising worldwide including Sub-Saharan Africa just as the incidence of ...
Objectives: Excess adiposity is associated with several factors involved in carcinogenesis and breas...
Purpose: The effects of body mass index on pathologic complete response and survival have not been r...
Breast cancer rarely occurs in women below the age of 35 years. Data from various sources indicate t...
Background: Breast cancer in young women is associated with aggressive biology. We analyzed histopat...
In locally advanced (LA) breast cancer (BC), neoadjuvant treatments have led to major achievements, ...
The role of neoadjuvant chemotherapy in locally advanced breast cancer is firmly established. There ...
Breast cancer represents the most frequent cancer among women in Western countries. Although physici...